| 000 | 01500 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513160648.0 | ||
| 264 | 0 | _c19990201 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0363-9045 | ||
| 024 | 7 |
_a10.3109/03639049809085652 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTimmermans, J | |
| 245 | 0 | 0 |
_aPeroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. II. Bioavailability and tolerance assessment in dogs. _h[electronic resource] |
| 260 |
_bDrug development and industrial pharmacy _cJun 1998 |
||
| 300 |
_a517-25 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aChemistry, Physical |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMorpholines _xadministration & dosage |
| 650 | 0 | 4 |
_aTriazines _xadministration & dosage |
| 700 | 1 | _aAmighi, K | |
| 700 | 1 | _aPuigdevall, J | |
| 700 | 1 | _aBaltes, E | |
| 700 | 1 | _aMoës, A J | |
| 773 | 0 |
_tDrug development and industrial pharmacy _gvol. 24 _gno. 6 _gp. 517-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/03639049809085652 _zAvailable from publisher's website |
| 999 |
_c9838998 _d9838998 |
||